Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Aug 04,2016
Single Protein Protects against Neurodegenerative Diseases
    A new study led by researchers at the University of Glasgow has identified how cells protect themselves against misfolded and aggregated proteins known to be the cause of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases. The researchers are hopeful that the results from this new study will provide needed insight into the biochemicalRead more
More
Single Protein Protects against Neurodegenerative Diseases
Aug 04,2016
Preclinical Trials Services in Drug Development
Medicilon has good preclinical trials services in drug development. Medicilon offers GLP and Non-GLP preclinical testing for the pharmaceutical and medical-device industries. We're tremendously proud of our environmentally controlled animal facilities, surgery suites and necropsy labs. However, we understand they're only a starting point for your preclinical studies. Key Preclinical Services Include: Preclinical Research ServiceRead more
More
Preclinical Trials Services in Drug Development
Aug 03,2016
Halting Translation of Cancer Promoting Proteins
    Most cancer drugs are designed to halt cell growth, the hallmark of cancer, and one popular target is the pathway that controls the production of a cell's thousands of proteins.     A familiar initiation factor, eukaryotic initiation factor 3 subunit d (eIF3d), has been found to harbor an unfamiliar feature—a sort of hidden compartment. What's more,Read more
More
Halting Translation of Cancer Promoting Proteins
Aug 03,2016
Recruiting KRAS to Attack Lung Cancer
    Scientists at the University of Texas Southwestern Medical Center say they have identified a new way to target lung cancer through the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene, one of the most commonly mutated genes in human cancer and one researchers have so far had difficulty targeting successfully.     Investigators studying the underlying biology of KRAS inRead more
More
Aug 02,2016
Gene Therapy Improves Metabolic Liver Disease Outcome
    Scientists at the Mayo Clinic are testing a new approach to correct metabolic liver disorders without a whole-organ transplant. Their findings ("Curative Ex Vivo Liver-Directed Gene Therapy in a Pig Model of Hereditary Tyrosinemia Type 1”) appear in Science Translational Medicine.     The medical research study tested gene therapy in pigs suffering from hereditary tyrosinemia typeRead more
More
Gene Therapy Improves Metabolic Liver Disease Outcome
Aug 02,2016
Genetic Factors Sculpt Cortical Patterns
    The ridges and valleys of the human cortex look sculpted—and in a sense, they are. In fact, these undulating shapes reflect the work of many tiny sculptors, genetic factors that work together to realize a developmental program that is remarkably consistent from individual to individual. These genetic factors remain mostly anonymous, but a new studyRead more
More
Genetic Factors Sculpt Cortical Patterns
Aug 01,2016
Sniffing Out Alzheimer Disease
    Our nose helps us identify odors, from a cup of coffee to the smoke of a cigarette. As we age, an impaired sense of smell is normal, but completely losing our sense of smell could be a sign of brain damage.       What if it were possible to predict cognitive decline and detect the earlyRead more
More
Sniffing Out Alzheimer Disease
Aug 01,2016
Patch Has Tumor Covered with Drug, Gene, and Light Therapy
It's an adhesive patch that is way more than a Band-Aid. And it's not just one of those medicated patches that are used to deliver nicotine, a contraceptive, or a pain killer. This patch is a triple-threat aimed straight at cancer. Once it is slapped on a tumor, it delivers a combination of drug, gene,Read more
More
Patch Has Tumor Covered with Drug, Gene, and Light Therapy
Jul 29,2016
Male Hormone Reverses Cell Aging
Telomerase, an enzyme naturally found in the human organism, is the closest of all known substances to a "cellular elixir of youth.”  The impact of the telomerase enzyme's discovery cannot be overstated, as its importance to cell biology was recognized in 2009 with the awarding of the Nobel Prize in Physiology or Medicine.
More
Male Hormone Reverses Cell Aging
Jul 29,2016
Old Malaria Drug May Have New Role Fighting Cancer
An old cancer drug can not only kill cancer cells, but also works to change how certain cancer cells function, weakening those cells so they can be killed by other drugs, a veterinary researcher has discovered. An off-patent antimalarial, atovaquone, has been utilized to boost cancer-killing capabilities of radiation. Atovaquone came into existence evaluated likeRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->